Saturday, November 22, 2014   

China to put Glaxo investigators on trial
(07-29 16:28)

A Shanghai court says American and British investigators who worked for drug maker GlaxoSmithKline will stand trial Aug. 8 on charges of illegally obtaining information on Chinese citizens.
The Shanghai No. 1 Intermediate People's Court said Tuesday that Yingzeng Yu and her husband Peter Humphrey will have a "public trial.'' Authorities had told U.S. and British diplomats they would be barred because the trial involved secret information but later reversed that decision.
Yu and Humphrey were detained last year and accused of improperly obtaining information such as home addresses of Chinese citizens for reports sold to corporate clients.
Yu and Humphrey worked for Glaxo, which faces an investigation into allegations it bribed doctors to use its medicines. Authorities have given no indication whether the two cases are connected. --AP   
Other China breaking news:
Uighur scholar's appeal rejected against life sentence (11-21 18:38)
Chinese journalist tried on state secrets charge (11-21 11:42)
7 killed in knife attack at military clinic (11-20 17:36)
China blocks websites as Internet meeting begins (11-20 11:22)
China seeks to cap coal use at 4.2b tonnes by 2020 (11-19 19:02)
China urges Internet 'security' amid rights criticism (11-19 16:25)
Rumormonger sentenced to four years in jail (11-18 16:32)
Researchers plan Mars mission 'around 2020': state media (11-18 12:03)
Man imprisoned for smuggling tiger bones, ivory (11-17 18:03)
Fire in food plant kills at least 18 (11-17 13:53)

More breaking news >>

© 2014 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2014, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.